Search research articles
Contact Us
Filters
Showing results (1-10 of 108) with videos related to
Page
of 11
Sort By:
Biometrics
|
December 15, 2007
A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes
Suzanne E Dahlberg, Molin Wang
The Oncologist
|
May 10, 2018
Interpretation of Results from Under-accruing Studies
Sasha Kravets, Suzanne E Dahlberg
Cancer
|
July 6, 2018
Pragmatic approaches to address expansion cohort design
Suzanne E Dahlberg, Robert J Gray
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2020
Reply to N. Hanna et al and L. Xie et al
Suresh S Ramalingam, Suzanne E Dahlberg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Improving Clinical Trial Efficiency: Thinking outside the Box
Sumithra J Mandrekar, Suzanne E Dahlberg, Richard Simon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2018
Evaluation of End Points in Cancer Clinical Trials
Jun Yin, Suzanne E Dahlberg, Sumithra J Mandrekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2022
Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes
Ticiana A Leal, Suzanne E Dahlberg, Suresh S Ramalingam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal
Suzanne E Dahlberg, Robert J Gray, Bruce E Johnson
The Journal of Pediatrics
|
August 9, 2025
The Impact of Inhaled Corticosteroids on Lung Inflammation and Clinical Outcomes in Children with Oropharyngeal Dysphagia
Kelly Quinn, Rachel Rosen, Rachel D'Anna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2013
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594
Tien Hoang, Suzanne E Dahlberg, Joan H Schiller, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 108) with videos related to
Sort By:
Page
of 11
Biometrics
|
December 15, 2007
A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes
Suzanne E Dahlberg, Molin Wang
The Oncologist
|
May 10, 2018
Interpretation of Results from Under-accruing Studies
Sasha Kravets, Suzanne E Dahlberg
Cancer
|
July 6, 2018
Pragmatic approaches to address expansion cohort design
Suzanne E Dahlberg, Robert J Gray
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2020
Reply to N. Hanna et al and L. Xie et al
Suresh S Ramalingam, Suzanne E Dahlberg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Improving Clinical Trial Efficiency: Thinking outside the Box
Sumithra J Mandrekar, Suzanne E Dahlberg, Richard Simon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2018
Evaluation of End Points in Cancer Clinical Trials
Jun Yin, Suzanne E Dahlberg, Sumithra J Mandrekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2022
Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes
Ticiana A Leal, Suzanne E Dahlberg, Suresh S Ramalingam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal
Suzanne E Dahlberg, Robert J Gray, Bruce E Johnson
The Journal of Pediatrics
|
August 9, 2025
The Impact of Inhaled Corticosteroids on Lung Inflammation and Clinical Outcomes in Children with Oropharyngeal Dysphagia
Kelly Quinn, Rachel Rosen, Rachel D'Anna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2013
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594
Tien Hoang, Suzanne E Dahlberg, Joan H Schiller, et al.
Page
of 11